Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/20/2025

Valvular Heart Disease

Introduction to Valvular Heart Disease

  • Age is a significant risk factor for calcific aortic stenosis and degenerative mitral valve disease, with varying risk profiles by geographic region and socioeconomic status, as suggested by the American College of Cardiology and Circulation journal 1, 2
  • Bicuspid aortic valve is a major risk factor for early-onset aortic valve disease, according to the American College of Cardiology and Circulation journal 1, 2
  • Elevated lipoprotein(a) levels are associated with increased risk of calcific aortic valve disease, as indicated by the American College of Cardiology and Circulation journal 1, 2

Rheumatic Heart Disease

  • Rheumatic fever remains the primary cause of valvular heart disease worldwide, particularly in developing countries, as stated by the European Heart Journal 3, 4
  • Prevention of rheumatic fever requires penicillin prophylaxis for at least 10 years after acute rheumatic fever or until age 40, as recommended by the European Heart Journal 3
  • High-risk patients may need lifelong prophylaxis depending on VHD severity and streptococcal exposure, according to the European Heart Journal 3

Infective Endocarditis

  • Previous endocarditis is a significant risk factor for recurrent disease, as suggested by the European Heart Journal 3
  • Prosthetic heart valves have a higher risk of endocarditis compared to native valves, according to the European Heart Journal 3
  • Poor oral hygiene and invasive procedures without proper antibiotic prophylaxis in high-risk patients increase the risk of endocarditis, as stated by the European Heart Journal 3

Systemic Diseases and Other Risk Factors

  • Autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, anti-phospholipid antibody syndrome, and ankylosing spondylitis are associated with valvular heart disease, as indicated by the Circulation journal 5
  • Certain medications, including ergotamine, methysergide, anorexiant medications (fenfluramine, dexfenfluramine), and pergolide (dopamine-receptor agonist), are established causes of valvular heart disease, according to the Circulation journal and ACC/AHA guidelines 6, 5
  • Mediastinal radiation causes calcification of valve leaflets and fibrous skeleton of the heart, typically manifesting at least 5 years after exposure, as indicated by the Circulation journal 5

Epidemiology and Increasing Prevalence

  • There is an increasing prevalence of valvular heart disease, particularly in aging populations, as stated by the European Heart Journal 7
  • Common causes of valvular heart disease include age-related degenerative changes, congenital abnormalities, rheumatic heart disease, infective endocarditis, and myxomatous degeneration, as identified by the ACC/AHA guidelines 6
  • Certain combinations of valvular heart disease, such as aortic stenosis + aortic regurgitation, are more common, as reported by the European Heart Journal 7
  • The following table summarizes the common causes of valvular heart disease:
Cause Description
Age-related degenerative changes Common cause of valvular heart disease
Congenital abnormalities Common cause of valvular heart disease
Rheumatic heart disease Primary cause of valvular heart disease worldwide
Infective endocarditis Significant risk factor for recurrent disease
Myxomatous degeneration Common cause of valvular heart disease
  • Risk factor assessment should focus on established causes of valvular disease, and treatment decisions should follow standard guidelines for valvular heart disease management, as recommended by the ACC/AHA guidelines and Circulation journal 6, 1

REFERENCES